{
    "title": "US to gain from banned flu drug",
    "url": "https://www.dailymail.co.uk/money/news/article-1576584/US-to-gain-from-banned-flu-drug.html",
    "date": "1999-10-23",
    "keywords": [
        "drug",
        "relenza",
        "health",
        "cost",
        "healthcare",
        "scheme",
        "approval",
        "giant",
        "government",
        "week",
        "insurance",
        "decision",
        "thapar",
        "gmt",
        "view",
        "access",
        "nhs",
        "medicaid",
        "glaxo",
        "breakthrough",
        "company",
        "seller",
        "roche",
        "advertising",
        "campaign",
        "americas",
        "medicare",
        "system",
        "news",
        "row",
        "britain",
        "flu",
        "year",
        "relenzas",
        "availability",
        "worldwide",
        "ban",
        "pressure",
        "france",
        "axa",
        "course",
        "chairman",
        "sir",
        "richard",
        "head",
        "office",
        "part",
        "testing",
        "programme",
        "institute",
        "excellence",
        "panel",
        "money",
        "anger",
        "industry",
        "attraction",
        "research",
        "centre",
        "firm",
        "uk",
        "betaferon",
        "treatment",
        "sclerosis"
    ],
    "category": [
        "money",
        "news"
    ]
}